Physician profile
Hailey Martin
NPI 1245043926
$1,194.28
in general payments reported to CMS, 2019-2025
19 companies · $1,194 in 2025
The $1,194 reported for 2025 was more than what 86% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $1,194.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,194.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,194.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $299.78 | 2025 | Ozempic, Wegovy, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $171.70 | 2025 | Breztri, Farxiga, Airsupra |
| Abbvie INC. | $145.39 | 2025 | |
| Lilly USA, LLC | $94.22 | 2025 | Zepbound, Mounjaro, Jardiance |
| Dexcom, INC. | $68.77 | 2025 | Dexcom G6 Transmitter |
| Otsuka America Pharmaceutical, INC. | $59.21 | 2025 | Rexulti |
| Axsome Therapeutics, INC. | $58.88 | 2025 | Auvelity |
| Takeda Pharmaceuticals U.S.A., INC. | $54.41 | 2025 | Trintellix |
| Astellas Pharma US INC | $42.17 | 2025 | Veozah |
| Globus Medical, INC. | $30.39 | 2025 | Senza |
| Bayer Healthcare Pharmaceuticals INC. | $28.56 | 2025 | |
| Abbott Laboratories | $22.40 | 2025 | Freestyle Libre |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $20.12 | 2025 | Caplyta |
| Viatris Specialty LLC | $19.96 | 2025 | Yupelri |
| Inspire Medical Systems, INC. | $18.73 | 2025 | Inspire |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $16.28 | 2025 | |
| Lundbeck LLC | $14.86 | 2025 | Rexulti |
| Eisai INC. | $14.73 | 2025 | |
| Glaxosmithkline, LLC. | $13.72 | 2025 | Shingrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hailey Martin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.